WallStSmart

Bio Green Med Solution, Inc. (BGMS)vsCarlisle Companies Incorporated (CSL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Carlisle Companies Incorporated generates 273785% more annual revenue ($5.10B vs $1.86M). CSL leads profitability with a 14.2% profit margin vs -118.3%. CSL earns a higher WallStSmart Score of 66/100 (B-).

BGMS

Hold

46

out of 100

Grade: D+

Growth: 6.3Profit: 2.0Value: 5.0Quality: 5.8
Piotroski: 4/9Altman Z: -77.25

CSL

Strong Buy

66

out of 100

Grade: B-

Growth: 4.7Profit: 8.0Value: 6.3Quality: 6.5
Piotroski: 3/9Altman Z: 3.52

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BGMS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
710.0%10/10

Revenue surging 710.0% year-over-year

CSL4 strengths · Avg: 9.0/10
Return on EquityProfitability
44.8%10/10

Every $100 of equity generates 45 in profit

Altman Z-ScoreHealth
3.5210/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.988/10

Growing faster than its price suggests

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Areas to Watch

BGMS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$5.78M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-46.1%2/10

ROE of -46.1% — below average capital efficiency

Free Cash FlowQuality
$-352,0002/10

Negative free cash flow — burning cash

CSL2 concerns · Avg: 3.0/10
Debt/EquityHealth
1.783/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BGMS

The strongest argument for BGMS centers on Price/Book, Revenue Growth. Revenue growth of 710.0% demonstrates continued momentum.

Bull Case : CSL

The strongest argument for CSL centers on Return on Equity, Altman Z-Score, PEG Ratio. PEG of 0.98 suggests the stock is reasonably priced for its growth.

Bear Case : BGMS

The primary concerns for BGMS are EPS Growth, Market Cap, Return on Equity.

Bear Case : CSL

The primary concerns for CSL are Debt/Equity, Piotroski F-Score. Debt-to-equity of 1.78 is elevated, increasing financial risk.

Key Dynamics to Monitor

BGMS profiles as a hypergrowth stock while CSL is a value play — different risk/reward profiles.

CSL carries more volatility with a beta of 0.83 — expect wider price swings.

BGMS is growing revenue faster at 710.0% — sustainability is the question.

CSL generates stronger free cash flow (200M), providing more financial flexibility.

Bottom Line

CSL scores higher overall (66/100 vs 46/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bio Green Med Solution, Inc.

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. The company is headquartered in Kuala Lumpur, Malaysia.

Carlisle Companies Incorporated

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Carlisle Companies Incorporated is a diversified manufacturer of engineered products in the United States, Europe, Asia, Canada, Mexico, the Middle East, Africa, and internationally. The company is headquartered in Scottsdale, Arizona.

Want to dig deeper into these stocks?